Dhampur Bio (India) Performance
| DBOL Stock | 126.64 1.10 0.88% |
The firm shows a Beta (market volatility) of -0.56, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Dhampur Bio are expected to decrease at a much lower rate. During the bear market, Dhampur Bio is likely to outperform the market. At this point, Dhampur Bio Organics has a negative expected return of -0.0628%. Please make sure to confirm Dhampur Bio's market risk adjusted performance, coefficient of variation, information ratio, as well as the relationship between the mean deviation and standard deviation , to decide if Dhampur Bio Organics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Dhampur Bio Organics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Dhampur Bio is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Forward Dividend Yield 0.0199 | Payout Ratio 1.5823 | Forward Dividend Rate 2.5 | Ex Dividend Date 2024-06-28 |
1 | Dhampur Bio Organics Is Looking To Continue Growing Its Returns On Capital - Simply Wall St | 09/23/2024 |
2 | Dhampur Bio Organics Reports Negative Q2 Results, Debtors Turnover Ratio at 5-Year High - MarketsMojo | 11/18/2024 |
| Begin Period Cash Flow | 1 B |
Dhampur |
Dhampur Bio Relative Risk vs. Return Landscape
If you would invest 13,523 in Dhampur Bio Organics on August 29, 2024 and sell it today you would lose (859.00) from holding Dhampur Bio Organics or give up 6.35% of portfolio value over 90 days. Dhampur Bio Organics is generating negative expected returns and assumes 2.979% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Dhampur, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Dhampur Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dhampur Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dhampur Bio Organics, and traders can use it to determine the average amount a Dhampur Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0211
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DBOL |
Estimated Market Risk
| 2.98 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Dhampur Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dhampur Bio by adding Dhampur Bio to a well-diversified portfolio.
Dhampur Bio Fundamentals Growth
Dhampur Stock prices reflect investors' perceptions of the future prospects and financial health of Dhampur Bio, and Dhampur Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dhampur Stock performance.
| Return On Equity | 0.0465 | ||||
| Return On Asset | 0.0266 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 13.72 B | ||||
| Shares Outstanding | 66.39 M | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 0.50 X | ||||
| Revenue | 18.39 B | ||||
| EBITDA | 1.59 B | ||||
| Net Income | 464.9 M | ||||
| Total Debt | 10.57 B | ||||
| Book Value Per Share | 146.37 X | ||||
| Cash Flow From Operations | (1.01 B) | ||||
| Earnings Per Share | 1.58 X | ||||
| Total Asset | 23.13 B | ||||
| Retained Earnings | 2.36 B | ||||
About Dhampur Bio Performance
Assessing Dhampur Bio's fundamental ratios provides investors with valuable insights into Dhampur Bio's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Dhampur Bio is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Dhampur Bio is entity of India. It is traded as Stock on NSE exchange.Things to note about Dhampur Bio Organics performance evaluation
Checking the ongoing alerts about Dhampur Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dhampur Bio Organics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dhampur Bio Organics generated a negative expected return over the last 90 days | |
| Dhampur Bio Organics is unlikely to experience financial distress in the next 2 years | |
| Dhampur Bio generates negative cash flow from operations | |
| About 65.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Dhampur Bio Organics Reports Negative Q2 Results, Debtors Turnover Ratio at 5-Year High - MarketsMojo |
- Analyzing Dhampur Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dhampur Bio's stock is overvalued or undervalued compared to its peers.
- Examining Dhampur Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dhampur Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dhampur Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dhampur Bio's stock. These opinions can provide insight into Dhampur Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Dhampur Stock Analysis
When running Dhampur Bio's price analysis, check to measure Dhampur Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dhampur Bio is operating at the current time. Most of Dhampur Bio's value examination focuses on studying past and present price action to predict the probability of Dhampur Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dhampur Bio's price. Additionally, you may evaluate how the addition of Dhampur Bio to your portfolios can decrease your overall portfolio volatility.